Skip to content
Disclosery

Wildcat Capital Management, LLC

Follow

13F filer, CIK 1582384, NEW YORK, NY

Wildcat Capital Management, LLC reported $204,604,763 across 7 holdings for the quarter ended 2024-09-30, in a 13F-HR filed 2024-11-08.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001839882-24-038436

Period
2024-09-30
Reported value
$205M
Holdings
7
Top 10 weight
100%
New
1
Sold out
10

Largest buys vs the previous quarter

SecurityShares changeApprox. value
SILEXION THERAPEUTICS CORPnew+1,020,852$536K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
FYBRexited-1,412,617-$37M
MCOexited-82,208-$34.6M
MSFTexited-75,000-$33.5M
GLBEexited-903,713-$32.8M
GSHDexited-516,008-$29.6M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2024

Share positions as resolved from 13F-HR 0001839882-24-038436, largest first. % of portfolio is the value over $204,604,763, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ULCCFRONTIER GROUP HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 28,061,351 shares 28,061,351$150M73.37%0Timeline
RLXRLX TECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 18,046,195 shares 18,046,195$32.7M15.96%0Timeline
ALLOALLOGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,920,787 shares 2,920,787$8.18M4%0Timeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 495,606 shares 495,606$6.29M3.08%0Timeline
SKILLZ INCSKILLZ INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 979,848 shares 979,848$5.51M2.69%0
KRONOS BIO INCKRONOS BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,297,959 shares 1,297,959$1.3M0.63%0
SILEXION THERAPEUTICS CORPSILEXION THERAPEUTICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,020,852 shares 1,020,852$536K0.26%new

Sold out in Q3 2024

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
FYBRFRONTIER COMMUNICATIONS PARE1,412,617$37Mshares
MCOMOODYS CORP82,208$34.6Mshares
MSFTMICROSOFT CORP75,000$33.5Mshares
GLBEGLOBAL E ONLINE LTD903,713$32.8Mshares
GSHDGOOSEHEAD INS INC516,008$29.6Mshares
DASHDOORDASH INC268,967$29.3Mshares
FLUTFLUTTER ENTMT PLC42,500$7.75Mshares
HLTHILTON WORLDWIDE HLDGS INC34,755$7.58Mshares
PCORPROCORE TECHNOLOGIES INC14,719$976Kshares
AKILI INCAKILI INC545,295$237Kshares

How Q3 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001839882-24-038436 base2024-11-08acceptance time not in the bulk data set